MIRA INFORM REPORT
|
Report Date : |
25.06.2014 |
IDENTIFICATION DETAILS
|
Name : |
BRISTOL-MYERS
SQUIBB INDIA PRIVATE LIMITED |
|
|
|
|
Registered
Office : |
The India Bulls Finance
Centre, 6th Floor, Tower 1, Senapati Bapat Marg, Elphinstone (West), Mumbai –
400013, Maharashtra |
|
|
|
|
Country : |
India |
|
|
|
|
Financials (as
on) : |
31.03.2013 |
|
|
|
|
Date of
Incorporation : |
30.06.2004 |
|
|
|
|
Com. Reg. No.: |
111-147232 |
|
|
|
|
Capital
Investment / Paid-up Capital : |
Rs.2069.090 Millions |
|
|
|
|
CIN No.: [Company Identification
No.] |
U24230MH2004FTC147232 |
|
|
|
|
TAN No.: [Tax Deduction &
Collection Account No.] |
MUMB14500D |
|
|
|
|
PAN No.: [Permanent Account No.] |
AACCB4313Q |
|
|
|
|
Legal Form : |
Private Limited Liability Company |
|
|
|
|
Line of Business
: |
Subject is engaged in the business of trading in pharmaceutical products |
|
|
|
|
No. of Employees
: |
Information denied by the management |
RATING & COMMENTS
|
MIRA’s Rating : |
B (29) |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
Status : |
Moderate |
|
|
|
|
Payment Behaviour : |
Slow |
|
|
|
|
Litigation : |
Clear |
|
|
|
|
Comments : |
Subject is a subsidiary of “Bristol-Myers Squibb Pharmaceuticals
International Holdings, Netherland BV” It is an established company having moderate track record. The company has recorded some accumulated losses from its operation
however, there are no borrowings recorded by the company. Trade relations are reported as fair. Business is active. Payments terms
are reported to be slow. The company can be considered for business dealings with some caution.
|
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
INDIAN ECONOMIC OVERVIEW
N E W S
The economy grew 4.7 %in 2013/14, marking a
second straight year of sub-5 % growth – the worst slowdown in more than a
quarter of a century. The data was below an official estimate of 4.9 % annual
growth and compared with 4.5 % in the last fiscal year. However, the current
account deficit narrowed sharply to $ 32.4 billion at 1.7 % of gross domestic
product, in 2013/14 from a record high of $ 98.8 billion or 4.7 %, the year before.A
sharp fall in gold imports due to restrictions on overseas purchases and muted
import of capital goods helped shrink the current account deficit.
Online retailer Flipkart has acquired fashion
portal Myntra as it prepares to battle with the rapidly expanding India arm of
the global e-commerce giant Amazon. The company raised $ 210 million from
Russian Investment firm DST Global which has also invested in companies like
Facebook, Twitter and Alibaba Group.
General Motors will start exporting vehicles from
its Talegaon plant near Pune in the second half of 2014. GM was one of the few
global carmakers that was using its India plant only for the domestic market.
Google has overtaken Apple as the world’s top
brand in terms of value, according to global market research agency Millward
Brown. Google’s brand value shot up 40 % in a year to $ 158.84 billion. The top
10 of the 100 slots were dominated by US companies.
Infosys lost another heavy weight when B G
Srinivas, a board member put in his papers. He is the third CEO-hopeful to quit
after Chairman N R Narayana Murthy’s return to the company – Ashok Vemuri and V
Balakrishnan being the other two.While Vemuri went on to lead IGate,
Balakrishnan joined politics.
Naresh Goyal – promoted Jet Airways posted
biggest quarterly loss – Rs 2153.37 crore – in the three months ended March 31,
mainly because it has been offering discounts to passengers to fill planes.
William S Pinckney – Chairman and CEO of
Amway India was arrested by the Andhra Pradesh Police in connection with a
complaint against the direct selling firm. This is the second time that he has
been taken into custody. A year, ago the Kerala Police had arrested Pinckney
and two company directors on charges of financial irregularities.
China has told its state-owned enterprises to
sever links with American consulting firms after the United States charged five
Chinese military officers wih hacking US companies. China’s action which
targets consultancies like McKinsey & Co. and the Boston Consulting Group,
sterns from fears that the first are providing trade secrets to the US
governments.
India has emerged as a country with some of
the highest unregistered businesses in the world. Indonesia has the maximum
number of shadow businesses, says a study of 68 countries by Imperial College
Business School in London.
Pfizer has abandoned its attempt to buy
AstraZeneca for nearly $ 118 billion after the latter refused an offer of 55
pounds a share.
RBI DEFAULTERS’ LIST STATUS
Subject’s name is not enlisted as a defaulter
in the publicly available RBI Defaulters’ list.
EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS
Subject’s name is not enlisted as a defaulter
in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of
31-03-2012.
INFORMATION DENIED
MANAGEMENT NON CO-OPERATIVE (91-22-66534200)
LOCATIONS
|
Registered Office : |
The India Bulls
Finance Centre, 6th Floor, Tower 1, Senapati Bapat Marg, Elphinstone (West),
Mumbai – 400013, Maharashtra, India |
|
Tel. No.: |
91-22-66534200 / 66288600 |
|
Fax No.: |
91-22-66103739 / 79 |
|
E-Mail : |
|
|
Website : |
DIRECTORS
As on 24.09.2013
|
Name : |
Pheroze Noshir Khan |
|
Designation : |
Managing director |
|
Address : |
20A, Kavafi Street 16673 Voul Athens Greece NA Athens Greece 16673 |
|
Date of Birth/Age : |
20.05.1958 |
|
Qualification : |
B. Sc, MBA |
|
Date of Appointment : |
30.06.2011 |
|
PAN No.: |
AEEPP4814P |
|
DIN No.: |
03563476 |
|
|
|
|
Name : |
Mr. Mukesh Surendra Agarwal |
|
Designation : |
Additional director |
|
Address : |
12 OAK Place Princeton New Jersey - 08540 United States of America |
|
Date of Birth/Age : |
15.01.1966 |
|
Date of Appointment : |
19.11.2011 |
|
PAN No.: |
AZIPA8317P |
|
DIN No.: |
05125036 |
KEY EXECUTIVES
|
Name : |
Mr. Bhavik Himatlal Desai |
|
Designation : |
Secretary |
|
Address : |
B 103, Gokul Nagar CHS, Off VS Road, Behind Parekh Nagar, Kandivali, Mumbai
– 400067, Maharashtra, India |
|
Date of Birth/Age : |
03.12.1978 |
|
Date of Appointment : |
05.03.2012 |
|
PAN No.: |
AGNPD1655M |
|
|
|
|
Name : |
Ms. Clara |
|
Designation : |
Admin Department |
|
|
|
|
Name : |
Harirajan Padmanabhan |
|
Designation : |
Business Unit Director - Diabetes |
|
|
|
|
Name : |
Mohan Pandey |
|
Designation : |
Head Operations & Project Management |
|
|
|
|
Name : |
Sandhya Mandlekar |
|
Designation : |
Head Candidate Optimization |
|
|
|
|
Name : |
Sridhar Desikan |
|
Designation : |
Head, Biopharmaceutics And Analytical Chemistry |
|
|
|
|
Name : |
Reeba Vikramadithyan |
|
Designation : |
Head In vivo Biology |
|
|
|
|
Name : |
Suresh Poosala |
|
Designation : |
Head Veterinary Sciences |
|
|
|
|
Name : |
Manjunath Ramarao |
|
Designation : |
Head Applied Biotechnology |
|
|
|
|
Name : |
Srinivas Kasibhatla |
|
Designation : |
Head Medicinal Chemistry |
|
|
|
|
Name : |
Deepa Joshi |
|
Designation : |
Head Discovery Medicines Critical Pharmacology |
MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN
As on 24.09.2013
|
Names of Shareholders |
No. of Shares |
|
Bristol-Myers Squibb Pharmaceuticals International Holdings,
Netherlands BV |
206908998 |
|
BMS Bermuda Nominees LLC, Wellington De |
01 |
|
|
|
|
Total |
206908999 |
As on 19.03.2014
|
Names of Allottee |
No. of Shares |
|
Bristol-Myers Squibb Pharmaceuticals International Holdings,
Netherlands BV |
40000000 |
|
|
|
|
Total |
40000000 |
As on 24.09.2013
Equity Share Break up (Percentage of Total Equity)
|
Category |
Percentage of Holding |
|
Foreign holdings( Foreign institutional
investor(s), Foreign companie(s) Foreign financial institution(s),
Non-resident Indian(s) or Overseas Corporate bodies or Others |
100.00 |
|
Total |
100.00 |
BUSINESS DETAILS
|
Line of Business : |
Subject is engaged in the business of trading in pharmaceutical products |
||||
|
|
|
||||
|
Products : |
|
GENERAL INFORMATION
|
No. of Employees : |
Information denied by the management |
|
|
|
|
Bankers : |
Not Divulged |
|
Banking
Relations : |
-- |
|
|
|
|
Auditors : |
|
|
Name : |
Deloitte Haskins and Sells Chartered Accountants |
|
Address : |
12, Dr. Annie Besant Road, Opposite Shiv Sagar Estate,
Worli, Mumbai, Maharashtra, India |
|
PAN
No. : |
AADFD2337G |
|
|
|
|
Holding company : |
¨ Bristol-Myers Squibb Pharmaceuticals International Holdings Netherlands BV |
|
|
|
|
Others : |
¨ Lawrence Laboratories ¨ Swords Laboratories ¨ BMS Holdings Pharma Limited ¨ Bristol Myers Squibb Company ¨ E. R. Squibb and Sons LLC ¨ Bristol-Myers Squibb (Singapore) Pte Limited ¨ Bristol-Myers Squibb Australia Pty Limited |
CAPITAL STRUCTURE
After 24.09.2013
Authorised Capital : Rs.2500.000
Millions
Issued, Subscribed & Paid-up Capital : Rs. 2469.090
Millions
As on 31.03.2013
Authorised Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
212500000 |
Equity Shares |
Rs.10/- each |
Rs.2125.000 Millions |
|
|
|
|
|
Issued, Subscribed & Paid-up Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
206908999 |
Equity Shares |
Rs.10/- each |
Rs.2069.090 Millions |
|
|
|
|
|
FINANCIAL DATA
[all figures are
in Rupees Millions]
ABRIDGED BALANCE
SHEET
|
SOURCES OF FUNDS |
31.03.2013 |
31.03.2012 |
31.03.2011 |
|
I.
EQUITY
AND LIABILITIES |
|
|
|
|
(1)Shareholders'
Funds |
|
|
|
|
(a) Share Capital |
2069.090 |
988.690 |
468.200 |
|
(b) Reserves & Surplus |
(1438.082) |
(1048.120) |
(940.737) |
|
(c) Money
received against share warrants |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
(2)
Share Application money pending allotment |
0.000 |
0.000 |
0.000 |
|
Total
Shareholders’ Funds (1) + (2) |
631.008 |
(59.430) |
(472.537) |
|
|
|
|
|
|
(3) Non-Current
Liabilities |
|
|
|
|
(a) long-term borrowings |
0.000 |
0.000 |
0.000 |
|
(b) Deferred tax liabilities (Net) |
0.000 |
0.000 |
0.000 |
|
(c) Other long term
liabilities |
0.000 |
0.000 |
0.000 |
|
(d) long-term
provisions |
111.267 |
54.498 |
43.930 |
|
Total Non-current
Liabilities (3) |
111.267 |
54.498 |
43.930 |
|
|
|
|
|
|
(4) Current Liabilities |
|
|
|
|
(a) Short
term borrowings |
0.000 |
0.000 |
538.194 |
|
(b) Trade
payables |
716.428 |
961.775 |
321.115 |
|
(c) Other
current liabilities |
123.361 |
59.236 |
36.936 |
|
(d) Short-term
provisions |
35.237 |
77.950 |
42.063 |
|
Total Current
Liabilities (4) |
875.026 |
1098.961 |
938.308 |
|
|
|
|
|
|
TOTAL |
1617.301 |
1094.029 |
509.701 |
|
|
|
|
|
|
II.
ASSETS |
|
|
|
|
(1) Non-current assets |
|
|
|
|
(a) Fixed
Assets |
|
|
|
|
(i) Tangible
assets |
153.375 |
11.655 |
16.031 |
|
(ii)
Intangible Assets |
0.000 |
0.000 |
0.000 |
|
(iii)
Capital work-in-progress |
0.000 |
0.000 |
0.000 |
|
(iv)
Intangible assets under development |
0.000 |
0.000 |
0.000 |
|
(b) Non-current Investments |
0.000 |
0.000 |
0.000 |
|
(c) Deferred tax assets (net) |
0.000 |
0.000 |
0.000 |
|
(d) Long-term Loan and Advances |
49.313 |
61.642 |
68.820 |
|
(e) Other
Non-current assets |
11.627 |
8.582 |
5.151 |
|
Total Non-Current
Assets |
214.315 |
81.879 |
90.002 |
|
|
|
|
|
|
(2) Current assets |
|
|
|
|
(a)
Current investments |
0.000 |
0.000 |
0.000 |
|
(b)
Inventories |
555.921 |
406.543 |
188.662 |
|
(c) Trade
receivables |
207.544 |
285.782 |
128.601 |
|
(d) Cash
and cash equivalents |
442.809 |
87.096 |
0.000 |
|
(e)
Short-term loans and advances |
194.330 |
207.398 |
102.390 |
|
(f) Other
current assets |
2.382 |
25.331 |
0.046 |
|
Total
Current Assets |
1402.986 |
1012.150 |
419.699 |
|
|
|
|
|
|
TOTAL |
1617.301 |
1094.029 |
509.701 |
PROFIT & LOSS ACCOUNT
|
|
PARTICULARS |
31.03.2013 |
31.03.2012 |
31.03.2011 |
|
|
|
SALES |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other Income |
|
|
|
|
|
|
TOTAL |
2260.870 |
2120.794 |
1512.008 |
|
|
|
|
|
|
|
|
Less |
EXPENSES |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Administrative Expenses |
|
|
|
|
|
|
Advertising Expenses |
|
|
|
|
|
|
TOTAL |
2621.760 |
2183.854 |
1696.625 |
|
|
|
|
|
|
|
|
|
PROFIT/
(LOSS) BEFORE INTEREST, TAX,
DEPRECIATION AND AMORTISATION |
(360.890) |
(63.060) |
(184.617) |
|
|
|
|
|
|
|
|
|
Less |
FINANCIAL
EXPENSES |
0.646 |
35.015 |
39.658 |
|
|
|
|
|
|
|
|
|
|
PROFIT
/ (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION |
(361.536) |
(98.075) |
(224.275) |
|
|
|
|
|
|
|
|
|
Less/ Add |
DEPRECIATION/
AMORTISATION |
28.425 |
9.307 |
13.119 |
|
|
|
|
|
|
|
|
|
|
PROFIT/
(LOSS) BEFORE TAX |
(389.961) |
(107.382) |
(237.394) |
|
|
|
|
|
|
|
|
|
Less |
TAX |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
|
|
PROFIT/
(LOSS) AFTER TAX |
(389.961) |
(107.382) |
(237.394) |
|
|
|
|
|
|
|
|
|
|
Earnings/ (Loss)
Per Share (Rs.) |
(1.88) |
(1.09) |
(5.07) |
|
KEY RATIOS
|
PARTICULARS |
|
31.03.2013 |
31.03.2012 |
31.03.2011 |
|
PAT / Total Income |
(%) |
(17.25) |
(5.06) |
(15.70) |
|
|
|
|
|
|
|
Return on Total Assets (PBT/Total Assets} |
(%) |
(24.11) |
(9.82) |
(46.58) |
|
|
|
|
|
|
|
Return on Investment (ROI) (PBT/Networth) |
|
(0.62) |
1.81 |
0.50 |
|
|
|
|
|
|
|
Debt Equity Ratio (Total Debt/Networth) |
|
0.00 |
0.00 |
(1.14) |
|
|
|
|
|
|
|
Current Ratio (Current Asset/Current Liability) |
|
1.60 |
0.92 |
0.45 |
FINANCIAL ANALYSIS
[all figures are
in Rupees Millions]
DEBT EQUITY RATIO
|
Particular |
31.03.2011 |
31.03.2012 |
31.03.2013 |
|
|
(Rs.
In Millions) |
(Rs.
In Millions) |
(Rs.
In Millions) |
|
Share Capital |
468.200 |
988.690 |
2069.090 |
|
Reserves & Surplus |
(940.737) |
(1048.120) |
(1438.082) |
|
Net
worth |
(472.537) |
(59.430) |
631.008 |
|
|
|
|
|
|
long-term borrowings |
0.000 |
0.000 |
0.000 |
|
Short term borrowings |
538.194 |
0.000 |
0.000 |
|
Total
borrowings |
538.194 |
0.000 |
0.000 |
|
Debt/Equity
ratio |
(1.139) |
0.000 |
0.000 |
YEAR-ON-YEAR GROWTH
|
Year
on Year Growth |
31.03.2011 |
31.03.2012 |
31.03.2013 |
|
|
(Rs.
In Millions) |
(Rs.
In Millions) |
(Rs.
In Millions) |
|
Sales |
1512.008 |
2120.794 |
2260.870 |
|
|
|
40.263 |
6.605 |
NET PROFIT MARGIN
|
Net
Profit Margin |
31.03.2011 |
31.03.2012 |
31.03.2013 |
|
|
(Rs.
In Millions) |
(Rs.
In Millions) |
(Rs.
In Millions) |
|
Sales |
1512.008 |
2120.794 |
2260.870 |
|
Profit |
(237.394) |
(107.382) |
(389.961) |
|
|
(15.70%) |
(5.06%) |
(17.25%) |
LOCAL AGENCY FURTHER INFORMATION
NOTE: Current
Maturities of Long Term Debts is Not Available.
|
Sr. No. |
Check List by Info Agents |
Available in
Report (Yes / No) |
|
1] |
Year of Establishment |
Yes |
|
2] |
Locality of the firm |
Yes |
|
3] |
Constitutions of the firm |
Yes |
|
4] |
Premises details |
No |
|
5] |
Type of Business |
Yes |
|
6] |
Line of Business |
Yes |
|
7] |
Promoter's background |
Yes |
|
8] |
No. of employees |
No |
|
9] |
Name of person contacted |
No |
|
10] |
Designation of contact
person |
No |
|
11] |
Turnover of firm for last
three years |
Yes |
|
12] |
Profitability for last
three years |
Yes |
|
13] |
Reasons for variation
<> 20% |
----- |
|
14] |
Estimation for coming
financial year |
No |
|
15] |
Capital in the business |
Yes |
|
16] |
Details of sister
concerns |
Yes |
|
17] |
Major suppliers |
No |
|
18] |
Major customers |
No |
|
19] |
Payments terms |
No |
|
20] |
Export / Import details (if
applicable) |
No |
|
21] |
Market information |
----- |
|
22] |
Litigations that the firm
/ promoter involved in |
----- |
|
23] |
Banking Details |
No |
|
24] |
Banking facility details |
No |
|
25] |
Conduct of the banking
account |
----- |
|
26] |
Buyer visit details |
----- |
|
27] |
Financials, if provided |
Yes |
|
28] |
Incorporation details, if
applicable |
Yes |
|
29] |
Last accounts filed at
ROC |
Yes |
|
30] |
Major Shareholders, if
available |
Yes |
|
31] |
Date of Birth of Proprietor/Partner/Director,
if available |
Yes |
|
32] |
PAN of
Proprietor/Partner/Director, if available |
No |
|
33] |
Voter ID No of
Proprietor/Partner/Director, if available |
No |
|
34] |
External Agency Rating,
if available |
No |
NOTE:
The registered address of the company has been shifted from 1st Floor,
'A' Block, Shiv Sagar Estate, Dr. Annie Besant Road, Worli, Mumbai - 400018,
Maharashtra, India to the present w.e.f. 06.08.2012
INDEX OF CHARGES
No Charges Exist for Company
PERFORMANCE DURING THE FINANCIAL YEAR:
Business performance and future
developments
The Company has earned an income of Rs. 2260.869 millions during the financial year as against Rs. 2120.794 millions during the previous Financial Year. However, the Company had incurred loss of Rs. 389.961 millions during the period 1st April, 2012 to 31st March, 2013 as compared to Rs 107.382 millions during the previous Financial Year.
FIXED ASSETS
œ Furniture and Fixtures
œ Office Equipment
œ Leasehold Improvements
œ Computer Software
CMT REPORT (Corruption, Money Laundering & Terrorism]
The Public Notice information has been collected from various sources
including but not limited to: The Courts,
1] INFORMATION ON
DESIGNATED PARTY
No exist designating subject or any of its beneficial owners,
controlling shareholders or senior officers as terrorist or terrorist
organization or whom notice had been received that all financial transactions
involving their assets have been blocked or convicted, found guilty or against
whom a judgement or order had been entered in a proceedings for violating
money-laundering, anti-corruption or bribery or international economic or
anti-terrorism sanction laws or whose assets were seized, blocked, frozen or
ordered forfeited for violation of money laundering or international
anti-terrorism laws.
2] Court Declaration :
No exist to suggest that subject is or was
the subject of any formal or informal allegations, prosecutions or other
official proceeding for making any prohibited payments or other improper
payments to government officials for engaging in prohibited transactions or
with designated parties.
3] Asset Declaration :
No records exist to suggest that the property or assets of the subject
are derived from criminal conduct or a prohibited transaction.
4] Record on Financial
Crime :
Charges or conviction
registered against subject: None
5] Records on Violation of
Anti-Corruption Laws :
Charges or
investigation registered against subject: None
6] Records on Int’l
Anti-Money Laundering Laws/Standards :
Charges or
investigation registered against subject: None
7] Criminal Records
No
available information exist that suggest that subject or any of its principals
have been formally charged or convicted by a competent governmental authority
for any financial crime or under any formal investigation by a competent
government authority for any violation of anti-corruption laws or international
anti-money laundering laws or standard.
8] Affiliation with
Government :
No record
exists to suggest that any director or indirect owners, controlling
shareholders, director, officer or employee of the company is a government official
or a family member or close business associate of a Government official.
9] Compensation Package :
Our market
survey revealed that the amount of compensation sought by the subject is fair
and reasonable and comparable to compensation paid to others for similar
services.
10] Press Report :
No press reports / filings exists on
the subject.
CORPORATE GOVERNANCE
MIRA INFORM as part of its Due Diligence do provide comments on
Corporate Governance to identify management and governance. These factors often
have been predictive and in some cases have created vulnerabilities to credit
deterioration.
Our Governance Assessment focuses principally on the interactions
between a company’s management, its Board of Directors, Shareholders and other
financial stakeholders.
CONTRAVENTION
Subject is not known to have contravened any existing local laws,
regulations or policies that prohibit, restrict or otherwise affect the terms
and conditions that could be included in the agreement with the subject.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.60.10 |
|
|
1 |
Rs.102.32 |
|
Euro |
1 |
Rs.81.75 |
INFORMATION DETAILS
|
Information
Gathered by : |
PRT |
|
|
|
|
Analysis Done by
: |
DIV |
|
|
|
|
Report Prepared
by : |
ANK |
SCORE & RATING EXPLANATIONS
|
SCORE FACTORS |
RANGE |
POINTS |
|
HISTORY |
1~10 |
3 |
|
PAID-UP CAPITAL |
1~10 |
5 |
|
OPERATING SCALE |
1~10 |
3 |
|
FINANCIAL CONDITION |
|
|
|
--BUSINESS SCALE |
1~10 |
4 |
|
--PROFITABILIRY |
1~10 |
2 |
|
--LIQUIDITY |
1~10 |
4 |
|
--LEVERAGE |
1~10 |
3 |
|
--RESERVES |
1~10 |
2 |
|
--CREDIT LINES |
1~10 |
3 |
|
--MARGINS |
-5~5 |
-- |
|
DEMERIT POINTS |
|
|
|
--BANK CHARGES |
YES/NO |
NO |
|
--LITIGATION |
YES/NO |
NO |
|
--OTHER ADVERSE INFORMATION |
YES/NO |
NO |
|
MERIT POINTS |
|
|
|
--SOLE DISTRIBUTORSHIP |
YES/NO |
NO |
|
--EXPORT ACTIVITIES |
YES/NO |
NO |
|
--AFFILIATION |
YES/NO |
YES |
|
--LISTED |
YES/NO |
NO |
|
--OTHER MERIT FACTORS |
YES/NO |
YES |
|
DEFAULTER |
|
|
|
--RBI |
YES/NO |
NO |
|
--EPF |
YES/NO |
NO |
|
TOTAL |
|
29 |
This score serves as a reference to assess
SC’s credit risk and to set the amount of credit to be extended. It is
calculated from a composite of weighted scores obtained from each of the major
sections of this report. The assessed factors and their relative weights (as
indicated through %) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend (10%) Operational size
(10%)
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with full
security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
-- |
NB |
New Business |
-- |
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or
its officials.